Clinical trial Recruiting at 1 site Observational Ages 65 and up

Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery

Official title: Intraoperative Dexmedetomidine for Prevention of Postoperative Delirium in Patients Undergoing Hip Fracture Surgery: a Pre-post Study

Run by Aarhus University Hospital · NCT07867899 · Data updated 2026-11-12

This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.

More Dexmedetomidine trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment242 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedMarch 31, 2027
Study endsApril 14, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07867899 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 65 or older undergoing hip fracture surgery (general or spinal anesthesia) in the defined study periods.

Probably not a fit

Patients with contraindications to dexmedetomidine or those not receiving prophylaxis during the defined periods may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Postoperative delirium is a common complication after hip fracture surgery, particularly in elderly patients with multiple health issues. This study examines whether implementing intraoperative dexmedetomidine prophylaxis reduces delirium by comparing outcomes before and after the prophylaxis program. Data will be drawn from patients undergoing hip fracture surgery under general or spinal anesthesia during defined pre- and post-implementation periods. Exclusion criteria include hypersensitivity to dexmedetomidine, certain heart rhythm blocks without a pacemaker, acute cerebral conditions affecting autoregulation, and severe liver failure. The study is led by Peter Gaarsdal Uhrbrand at Aarhus University Hospital with anesthesiology staff as the collaborating team.

Why it matters

Potential benefit: If successful, the approach could lower delirium rates after hip fracture surgery, potentially improving recovery and reducing complications.

How similar studies have gone: Previous work has explored dexmedetomidine for delirium prevention in surgical settings, but evidence specific to hip fracture surgery and a before/after prophylaxis implementation is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients at least 65 years of age undergoing surgery for hip fracture in general or spinal anesthesia
* Treated during the defined pre- or post-implementation period

Exclusion Criteria:

* Known hypersensitivity to dexmedetomidine
* Second- or third-degree AV block without pacemaker
* Acute cerebral conditions with potentially impaired cerebral autoregulation
* Acute or chronic liver failure

Where it's running

  • Department of Anesthesiology, Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.